MY182059A - Pharmaceutical composition for external use - Google Patents

Pharmaceutical composition for external use

Info

Publication number
MY182059A
MY182059A MYPI2016703598A MYPI2016703598A MY182059A MY 182059 A MY182059 A MY 182059A MY PI2016703598 A MYPI2016703598 A MY PI2016703598A MY PI2016703598 A MYPI2016703598 A MY PI2016703598A MY 182059 A MY182059 A MY 182059A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical composition
external use
tocopherol
derivative
diclofenac
Prior art date
Application number
MYPI2016703598A
Inventor
Kazuyoshi Ado
Kozue Imai
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Publication of MY182059A publication Critical patent/MY182059A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

[Problem to be solved] The objective of the present invention is to provide a formulation technique that can suppress cloudiness and the formation of precipitate to provide excellent appearance characteristics, while incorporating diclofenac and a tocopherol and/or a derivative thereof into a pharmaceutical composition for external use containing water. [Solution] When menthol is blended into a pharmaceutical composition for external use containing diclofenac and/or a salt thereof, a tocopherol and/or a derivative thereof, and water, cloudiness and the formation of precipitate due to diclofenac and/or a salt thereof and a tocopherol and/or a derivative thereof can be suppressed, and excellent appearance characteristics can be provided in the pharmaceutical composition for external use.
MYPI2016703598A 2014-03-30 2015-03-26 Pharmaceutical composition for external use MY182059A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014070678A JP6580305B2 (en) 2014-03-30 2014-03-30 Pharmaceutical composition for external use
PCT/JP2015/059323 WO2015151990A1 (en) 2014-03-30 2015-03-26 Pharmaceutical composition for external use

Publications (1)

Publication Number Publication Date
MY182059A true MY182059A (en) 2021-01-18

Family

ID=54240316

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2016703598A MY182059A (en) 2014-03-30 2015-03-26 Pharmaceutical composition for external use

Country Status (6)

Country Link
JP (1) JP6580305B2 (en)
CN (1) CN106456598B (en)
MY (1) MY182059A (en)
SG (2) SG11201608123VA (en)
TW (1) TWI712408B (en)
WO (1) WO2015151990A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7086596B2 (en) * 2017-12-28 2022-06-20 小林製薬株式会社 External composition
JP7086597B2 (en) * 2017-12-28 2022-06-20 小林製薬株式会社 External composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5976013A (en) * 1982-10-23 1984-04-28 Toko Yakuhin Kogyo Kk Gelatinous pharmaceutical for surgical use
JP3044352B2 (en) * 1989-11-20 2000-05-22 ライオン株式会社 Patch
WO1992007561A1 (en) * 1990-10-30 1992-05-14 Ss Pharmaceutical Co., Ltd. Antiphlogistic and analgesic gel preparation
JP3100408B2 (en) * 1991-03-26 2000-10-16 株式会社資生堂 Skin external preparation containing diclofenac sodium
JPH11255644A (en) * 1998-03-09 1999-09-21 Lintec Corp Percutaneous absorption type antipyretic antiphlogistic analgesic
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
JP4820065B2 (en) * 2004-05-24 2011-11-24 同仁医薬化工株式会社 Anti-inflammatory analgesic topical aqueous solution
AR051397A1 (en) * 2004-10-21 2007-01-10 Novartis Ag PHARMACEUTICAL COMPOSITION
CH699814B1 (en) * 2007-05-14 2010-05-14 Mepha Ag Diclofenac for topical application as a spray.
CN101790370B (en) * 2007-06-08 2013-06-12 特罗伊卡药品有限公司 A novel non-aqueous topical solution of diclofenac and process for preparing the same
WO2010087947A2 (en) * 2009-01-30 2010-08-05 Kydes Pharmaceuticals, Llc Transdermal delivery of diclofenac, carbamazepine and benzydamine
JP5421063B2 (en) * 2009-10-23 2014-02-19 帝國製薬株式会社 Diclofenac sodium-containing aqueous patch
US8889659B2 (en) * 2011-09-09 2014-11-18 Api Genesis, Llc Pain relief compositions, manufacture and uses
JP6738120B2 (en) * 2013-03-29 2020-08-12 小林製薬株式会社 External pharmaceutical composition

Also Published As

Publication number Publication date
SG11201608123VA (en) 2016-11-29
CN106456598A (en) 2017-02-22
TWI712408B (en) 2020-12-11
JP6580305B2 (en) 2019-09-25
JP2015189760A (en) 2015-11-02
TW201622712A (en) 2016-07-01
SG10201810093PA (en) 2018-12-28
CN106456598B (en) 2020-06-02
WO2015151990A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
PH12016501898B1 (en) Quinoxaline derivatives useful as fgfr kinase modulators
EP4356736A3 (en) Synthesis of boronate salts
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2015010125A (en) Pyridazinone-amides derivatives.
MX2015008628A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2021011906A (en) Delayed release compositions of linaclotide.
GB201106743D0 (en) Novel compounds
MX2015015518A (en) Methods and compositions for the treatment of cancer.
MY181602A (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
MA39710A (en) Topical composition for use in the treatment of inflammatory bowel disease
IN2015DN03998A (en)
SA517381678B1 (en) Dihydropyrimidin-2-One Compounds and Medical Use Thereof
EA032271B9 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
PH12018501709A1 (en) Naphthridinedione derivatives
IN2014DN10449A (en)
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MX2016000313A (en) Novel light stabilizers.
MX2016000219A (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods.
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
MX2016004909A (en) Composition containing eugenol as active ingredient for preventing or treating atopic dermatitis.
MX2015013755A (en) Pharmaceutical formulation for use in the treatment and/or prevention of restenosis.
MY182059A (en) Pharmaceutical composition for external use